We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AstraZeneca and Abbott Partner

News   May 14, 2015

 
AstraZeneca and Abbott Partner
 
 
 

RELATED ARTICLES

New Regulators of Macrophage Pyroptosis

News

Two enzymes, TAK1 and IKK, have been identified as important kinases involved in the regulation of pyroptosis - a highly inflammatory form of programmed cell death, which often forms part of the antimicrobial response.

READ MORE

Sprayable Gel Could Help the Body Fight Off Cancer After Surgery

News

Almost 95% of people with early-diagnosed breast cancer will require surgery and it’s often the first line of treatment for people with brain tumors, for example. But despite improvements in surgical techniques over the past decade, the cancer often comes back after the procedure. Now, a team has developed a spray gel embedded with immune-boosting drugs that could help.

READ MORE

Bacterial ‘Sleeper Cells’ Evade Antibiotics and Weaken Defence Against Infection

News

These bacteria persister cells stop replicating and can remain in this dormant, ‘sleeper-cell’ state for days, weeks or even months. When antibiotic treatment has been stopped, if some of these bacterial cells spring back to life, they can trigger another infection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE